Cite
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study.
MLA
Kick, Anastas, et al. “Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study.” Diabetes Therapy, vol. 15, no. 3, Mar. 2024, pp. 623–37. EBSCOhost, https://doi.org/10.1007/s13300-023-01525-y.
APA
Kick, A., M’Rabet-Bensalah, K., Acquistapace, F., Amadid, H., Ambühl, R. A., Braae, U. C., Item, F., Schultes, B., Züger, T., & Rudofsky, G. (2024). Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study. Diabetes Therapy, 15(3), 623–637. https://doi.org/10.1007/s13300-023-01525-y
Chicago
Kick, Anastas, Khadija M’Rabet-Bensalah, Flavio Acquistapace, Hanan Amadid, Robert A. Ambühl, Uffe Christian Braae, Flurin Item, Bernd Schultes, Thomas Züger, and Gottfried Rudofsky. 2024. “Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study.” Diabetes Therapy 15 (3): 623–37. doi:10.1007/s13300-023-01525-y.